SCHEMBL3464451

SCHEMBL3464451

C=CCOc1ccc(C=O)cc1OCC=C

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FDPS P14324 1/20 0.54
ALDH1A1 P00352 7/20 0.49
TSHR P16473 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
MAPT P10636 2/20 0.48
NPSR1 Q6W5P4 2/20 0.48
LMNA P02545 1/20 0.48
HTT P42858 1/20 0.48
PDE4B Q07343 2/20 0.47
TACR2 P21452 1/20 0.47
HPGD P15428 2/20 0.44
TDP1 Q9NUW8 2/20 0.44
TRIM24 O15164 1/20 0.44
ALDH5A1 P51649 1/20 0.44
ABAT P80404 1/20 0.44
TRIM33 Q9UPN9 1/20 0.44
KDM4E B2RXH2 1/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
GAA P10253 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3133543 0.92 ALDH1A1 (0.62) FDPSALDH1A1TSHRMAPTNPSR1
SCHEMBL1396839 0.90 FDPS (0.71) FDPSALDH1A1TSHRSMN1; SMN2MAPT
SCHEMBL1748511 0.90 ALDH1A1 (0.66) FDPSALDH1A1TSHRSMN1; SMN2MAPT
SCHEMBL29652045 0.90 FDPS (0.71) FDPSALDH1A1TSHRSMN1; SMN2MAPT
SCHEMBL11721524 0.86 ALDH1A1 (0.68) FDPSALDH1A1TSHRHPGDTDP1
SCHEMBL1923931 0.86 ALDH1A1 (0.46) FDPSALDH1A1TSHRSMN1; SMN2HTT
SCHEMBL24201975 0.85 PTGS1 (0.48) FDPSALDH1A1TSHRSMN1; SMN2MAPT
SCHEMBL18095839 0.84 ALDH1A1 (0.49) FDPSALDH1A1TSHRSMN1; SMN2PDE4B
SCHEMBL944430 0.84 ALDH1A1 (0.48) FDPSALDH1A1TSHRSMN1; SMN2MAPT
SCHEMBL4617044 0.84 TSHR (0.44) FDPSALDH1A1TSHRSMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100240654-A1 HYDRAZIDE DERIVATIVES CLARK RICHARD 2010-09-23 US disclosed
US-20080132507-A1 Hydrazide Derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2008-06-05 US disclosed
EP-1810965-A1 HYDRAZIDE DERIVATIVES Eisai R&D Management Co., Ltd. (JP) 2007-07-25 EP disclosed
EP-0472062-A1 Beta-lactam compounds, and their production and use SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1992-02-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240654-A1 HYDRAZIDE DERIVATIVES H1-10, H1-4, H1-3 FDPS 4153/4885ALDH1A1 192/4885TSHR 323/4885
US-20080132507-A1 Hydrazide Derivatives H1-10, H1-4, H1-3 FDPS 4153/4885ALDH1A1 192/4885TSHR 323/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.